Ritesh Patil

Clinical trial results of the HER‐2/<i>neu</i> (E75) vaccine to prevent breast cancer recurrence in high‐risk patients

Elizabeth A. Mittendorf, Guy T. Clifton, Jarrod P. Holmes et al. · Cancer · 2011 · 170 citations · Full text

Optimal dose and schedule of an HER‐2/<i>neu</i> (E75) peptide vaccine to prevent breast cancer recurrence

Jarrod P. Holmes, Jeremy D. Gates, Linda C. Benavides et al. · Cancer · 2008 · 50 citations · Full text

Clinical and Immunologic Responses of HLA-A3+ Breast Cancer Patients Vaccinated with the HER2/ neu -Derived Peptide Vaccine, E75, in a Phase I/II Clinical Trial

Ritesh Patil, Guy T. Clifton, Jarrod P. Holmes et al. · Journal of the American College of Surgeons · 2009 · 49 citations

Use of booster inoculations to sustain the clinical effect of an adjuvant breast cancer vaccine

Jarrod P. Holmes, Guy T. Clifton, Ritesh Patil et al. · Cancer · 2010 · 48 citations · Full text

Primary analysis of the prospective, randomized, single-blinded phase II trial of AE37 vaccine versus GM-CSF alone administered in the adjuvant setting to high-risk breast cancer patients.

Elizabeth A. Mittendorf, Erika J Schneble, Sonia A. Perez et al. · Journal of Clinical Oncology · 2014 · 10 citations

Breast Oncology, Immunology, Ae37 Vaccine +24